Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Similar documents
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Pennsylvania Prescription Drug Monitoring Program Trends,

Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call

A National Perspective on the Abuse and Diversion of Prescription Drugs

Getting High on Prescription Drug Safety in Kentucky- Research to Policy

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-16-15BBT]

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky Hal Rogers PDMP Grant. Action Team Meeting.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Drug Overdose Fatality Surveillance System (DOFSS) 2015 Annual Report

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016

Michael M. Miller, MD, FASAM, FAPA

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Drug Overdose Morbidity and Mortality in Kentucky,

Drug Overdose Deaths, Hospitalizations, and Emergency Department Visits in Kentucky,

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Opioid Overdose in Oregon Report to the Legislature

Drug Overdose Deaths among Kentucky Residents, December, 2018

TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

2017 NASCSA Conference

Montgomery County Poisoning Death Review:

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

Oregon s PDMP: An epidemiological assist tool

Overdose Fatality Review

Prescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data

BC Coroners Service Prescription Opiate-Related Overdose Deaths

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

RECO M M EN D AT IO N S A N D LESSO N S LEA RN ED FO R IM P RO VED REP O RT IN G O FD RU G O VERD O SE D EAT H S O N D EAT H CERT IFICAT ES

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Kansas Prescription Drug and Opioid Advisory Committee

2017 CSTE Annual Conference. Analysis and Reporting of Injury-Related Inpatient Hospitalizations Using ICD-10-CM-coded Administrative Billing Data

OFFICE OF THE CORONER Annual Statistical Report. Mark J. Ward, Coroner th Street, Ste 325 Greeley, CO Website:

Ingham County Opioid Surveillance

Montgomery County Poisoning Death Review

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

Dr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force

BJA COAP Category 6 Quarterly Webinar November 29, 2018

ACCG Mental Health Summit

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

The Price of Injury The Burden of Injury and the Legislative Actions to Prevent Injury

Harold Rogers Update Melissa McPheeters, PhD, MPH

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Oregon Prescription Drug Monitoring Program

May 25, Drug Overdose Update & Response: Combatting Opioid Overdose

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

PRESCRIPTION DRUG MONITORING PROGRAM

DRUG OVERDOSE DEATHS ANALYSIS

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

COUNTY OF SAN DIEGO. Opioid Update

Natural Deaths 61 Investigated/PND 14 Accidental Deaths 123 Suicides 37 Homicides 8 Stillborn 2 SUIDS 1 Cannot Be Determined 4 Pending 0

State Opioid Response (SOR) Grant

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Arkansas Prescription Monitoring Program

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Prescribing Controlled Substances and the PDMP

Maryland Epidemiological Profiles on Alcohol

Prescription Behavior Surveillance System Len Paulozzi, MD, MPH

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

The Regional Judicial Opioid Initiative

PDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Opioid use in pregnancy and Neonatal Abstinence Syndrome

White Paper on. Prescription Drug Abuse

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Figure 1. Fentanyl-Related Drug Overdoses, Ohio,

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

Overdose Fatality Review Presentation of Annual Reports. Erin Haas and Laura Bartolomei-Hill Maryland Department of Health

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

Mark W. Caverly, Chief Liaison and Policy Section

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Report to the Legislature: Recommendations on Required Use and Other Uses of the MN Prescription Monitoring Program Database

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Poisoning Death Review Report. Montgomery County, 2017

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

Transcription:

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots National Meeting August 15, 2016 Washington DC

Two major programs support the data integration and analysis of drug use and drug-related health outcome data in Kentucky: Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky (Funded by BJA; start date Oct 1, 2014) And Kentucky Drug Overdose Prevention (Funded by CDC, start date Sept 1, 2015)

The BJA-funded Data-driven pilot program established a solid background for multi-source data collection, integration, and analysis: Major activities: - Established data use agreements between state agencies - Piloted multi-source data collection, linkage and analysis - Developed and implemented enhanced PDMP analytical capabilities - Formed a multi-disciplinary, multiagency Action Team to review drug-related data analysis results and guide program activities

The CDC-funded Drug Overdose Prevention program ensured sustainability and expansion of the results from the Data-driven pilot: Major activities: Comprehensive drug overdose fatality surveillance system (integration of death certificate, coroner investigation, autopsy report, post-mortem toxicology testing, and controlled substance prescription history data Enhancement of electronic patient PDMP reports that enables practitioners to better identify patients at increased risk for overdoses Utilization of PDMP data for public health surveillance and research Integration of patient PDMP reports into Electronic Health Records

The Kentucky Injury Prevention and Research Center (KIPRC), a bona fide agent for the Kentucky Department for Public Health, became a state repository for drug overdose and drug use data and analysis by establishing data sharing agreements with Kentucky Office of Vital Statistics (electronic death certificate records) Kentucky Office of the Chief Medical Examiner (drug overdose autopsy, post-mortem toxicology, and coroner reports) Kentucky All Schedule Prescription Electronic Reporting (KASPER), Office of the Inspector General (prescription drug monitoring program data) Kentucky Office of Health Policy (inpatient hospitalization and emergency department visit administrative billing records) Kentucky State Police (police crash reports) Additional data sources: Kentucky Trauma Registry ( KIPRC is the single statewide trauma registry repository per 902 KAR 28:040) Kentucky Syndromic Surveillance data ( KIPRC, as an agent for the Ky Department for Public Health, has access to these records through CDC BioSense)

Linkage of 2013-2014 death certificates for Ky drug overdose decedents and PDMP records to identify controlled substance prescribing patterns

Linkage of 2013-2014 death certificates for Ky drug overdose decedents and PDMP records to identify controlled substance prescribing patterns

Linkage of 2013-2014 toxicology reports for Ky drug overdose decedents and PDMP records to identify possible involvement of diverted Rx drugs Were there current prescriptions for controlled substances identified in toxicology reports? Percentage of Ky decedents with a current controlled substance prescription (as of the day of the death) for the drug present in the post-mortem toxicology report Alprazolam Buprenorphine Clonazepam Diazepam Fentanyl Hydrocodone Hydromorphone* Methadone Morphine* Oxycodone Oxymorphone* Tramadol 6.3% 0.8% 4.1% 2.6% 14.6% 13.2% 22.2% 32.4% 40.0% 41.7% 36.2% 37.0% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0%

Death certificates do not always list the specific drugs involved in overdose deaths thus leading to underestimation of the contribution of some drugs to the overdose epidemic.

Linkage of 2013-2014 drug overdose death certificates and toxicology reports to access the completeness and accuracy of the death certificate text related to specific drugs involved in drug overdose deaths

Kentucky Comprehensive Drug Overdose Fatality Surveillance (data sources: death certificates, coroner investigation reports, medical examiner autopsy reports, toxicology reports, PDMP records)

Linkage between trauma registry data and police crash reports to improve the identification of drugs involved in motor vehicle crashes leading to trauma center treatment in Kentucky Results: Drug involvement was listed as a human factor on police reports for 61(3%) of the 1,774 injured drivers treated in Ky trauma facilities in 2013. For 20 of these 61 drivers the trauma registry data (TR) listed illegal use of drugs (prescription of illicit) confirmed by a test; for additional 20 cases the TR listed presence of prescription drugs confirmed by test. The TR data identified additional 126 drivers with illegal use of drugs confirmed by tests who s police report didn t list drug involvement as human factor. TR listed 503 drivers with presence of prescription drugs confirmed by tests (indicating that the drugs were taken according to a prescription or the trauma registrars didn t have enough information to classify the prescription drugs showing on the toxicology screen as illegal prescription drugs). Overall, only 19 of the 145 cases identified as illegal use of drugs in the TR were listed as drug involvement on the police report.

Linkage between inpatient & emergency department discharge data and police crash reports for identification of drugs in injured drivers Bunn, T., Singleton, M., Nicholson, V., & Slavova, S. (2013). Concordance of motor vehicle crash, emergency department, and inpatient hospitalization data sets in the identification of drugs in injured drivers. Traffic Inj Prev, 14(7), 680-689. doi: 10.1080/15389588.2012.757310

Improved recognition of specific drugs contributing to Kentucky resident drug overdoses and injuries is needed to: - Identify emerging trends in drug abuse and diversion - Evaluate the effectiveness of prescription drug overdose prevention laws [e.g., Kentucky House Bill 1 from the 2012 Special Session (KRS 218A.172; KRS 218A.175; KRS 72.026) and subsequent licensing board regulations (201 KAR 8-540, 9-260, 20-057)] - Inform new interventions, continuing education, law enforcement training, and state and local policy changes

Conclusions: Kentucky public health officials, regulatory boards, and law enforcement need multiple sources of drug-related data to inform data-driven decisions that address controlled substance abuse and diversion at state and local levels. Integrated multi-source drug use and overdose surveillance data allows better identification of drug diversion, harmful prescribing practices, and informs targeted state and local prescriber education, law enforcement, policy and program evaluation, and surveillance quality improvement.

Svetla Slavova ssslav2@email.uky.edu